These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Weaver CH, Schulman KA, Buckner CD. Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117 [Abstract] [Full Text] [Related]
3. GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation. Zumberg MS, Leather HL, Nejame C, Meyer C, Wingard JR. Cytotherapy; 2002 May; 4(6):531-8. PubMed ID: 12568989 [Abstract] [Full Text] [Related]
4. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]
5. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R. Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688 [Abstract] [Full Text] [Related]
6. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy. Spitzer G, Adkins D, Mathews M, Velasquez W, Bowers C, Dunphy F, Kronmueller N, Niemeyer R, McIntyre W, Petruska P. Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470 [Abstract] [Full Text] [Related]
7. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P. Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784 [Abstract] [Full Text] [Related]
8. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation. Greenberg P, Advani R, Keating A, Gulati SC, Nimer S, Champlin R, Karanes C, Gorin NC, Powles RL, Smith A, Lamborn K, Cuffie C. Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373 [Abstract] [Full Text] [Related]
9. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation. Bence-Bruckler I, Bredeson C, Atkins H, McDiarmid S, Hamelin L, Hopkins H, Perry G, Genest P, Huebsch L. Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693 [Abstract] [Full Text] [Related]
10. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Alegre A, Tomás JF, Martínez-Chamorro C, Gil-Fernández JJ, Fernández-Villalta MJ, Arranz R, Díaz MA, Granda A, Bernardo MR, Escudero A, López-Lorenzo JL, Fernández-Rañada JM. Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889 [Abstract] [Full Text] [Related]
11. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bolwell BJ, Goormastic M, Yanssens T, Dannley R, Baucco P, Fishleder A. Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072 [Abstract] [Full Text] [Related]
12. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients. Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F. Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956 [Abstract] [Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H. Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683 [Abstract] [Full Text] [Related]
14. Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation. Cetkovský P, Koza V, Jindra P, Skopek P, Svojgrová M. Bone Marrow Transplant; 1997 Oct; 20(8):639-41. PubMed ID: 9383226 [Abstract] [Full Text] [Related]
15. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, Sempere A, Soler MA, Marty ML, Sanz MA. Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232 [Abstract] [Full Text] [Related]
16. Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma. Ossenkoppele GJ, Jonkhoff AR, Huijgens PC, Nauta JJ, van der Hem KG, Dräger AM, Langenhuijsen MM. Bone Marrow Transplant; 1994 Jan; 13(1):37-41. PubMed ID: 7517255 [Abstract] [Full Text] [Related]
17. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Brice P, Divine M, Marolleau JP, Haioun C, Dalcortivo L, Sitthy X, Beaujean F, Norol F, Benbunan M, Reyes F. Bone Marrow Transplant; 1994 Jul; 14(1):51-5. PubMed ID: 7524907 [Abstract] [Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial. Bernstein SH, Christiansen NP, Fay JP, Brown R, Herzig R, Frankel S, Blumenson L, Herzig GP. Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281 [Abstract] [Full Text] [Related]
19. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature. Jacoub JF, Suryadevara U, Pereyra V, Colón D, Fontelonga A, Mackintosh FR, Hall SW, Ascensão JL. Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563 [Abstract] [Full Text] [Related]
20. G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Tarella C, Castellino C, Locatelli F, Caracciolo D, Corradini P, Falda M, Novarino A, Tassi V, Pileri A. Bone Marrow Transplant; 1998 Feb; 21(4):401-7. PubMed ID: 9509976 [Abstract] [Full Text] [Related] Page: [Next] [New Search]